Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)

ClinicalTrials.gov ID: NCT00754065

Public ClinicalTrials.gov record NCT00754065. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Group, 2-arm Study to Show Superiority of the Oral Contraceptive SH T00658ID Over Ortho Tri-Cyclen Lo on Hormone Withdrawal-associated Symptoms After 6 Cycles of Treatment.

Study identification

NCT ID
NCT00754065
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
409 participants

Conditions and interventions

Conditions

Interventions

  • Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027) Drug
  • Ortho Tri Cyclen Lo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 7, 2008
Primary completion
May 9, 2011
Completion
May 9, 2011
Last update posted
Nov 19, 2024

2008 – 2011

United States locations

U.S. sites
34
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Not listed Independence Arizona 94925
Not listed Phoenix Arizona 85032
Not listed Encinitas California 92024
Not listed San Diego California 92108
Not listed Santa Monica California 90404
Not listed Denver Colorado 80206
Not listed Denver Colorado 80218
Not listed Littleton Colorado 80127
Not listed Clearwater Florida 33759
Not listed Jacksonville Florida 32207
Not listed West Palm Beach Florida 33409
Not listed Decatur Georgia 30034
Not listed Boise Idaho 83702
Not listed Boise Idaho 83712
Not listed Idaho Falls Idaho 83406
Not listed Fishers Indiana 46037
Not listed Indianapolis Indiana 46217
Not listed South Bend Indiana 46601
Not listed Metairie Louisiana 70006
Not listed Chesterfield Missouri 63017
Not listed St Louis Missouri 63141
Not listed Lincoln Nebraska 68510
Not listed Las Vegas Nevada 89128
Not listed New Brunswick New Jersey 08901
Not listed Winston-Salem North Carolina 94925
Not listed Cincinnati Ohio 45246
Not listed Columbus Ohio 43213
Not listed Portland Oregon 97239-3011
Not listed Philadelphia Pennsylvania 19114
Not listed Bristol Tennessee 37620
Not listed Memphis Tennessee 38120
Not listed Houston Texas 77054
Not listed Spokane Washington 99207
Not listed La Crosse Wisconsin 54601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00754065, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00754065 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →